Plasma, the liquid component of blood, contains various clotting factors, which are essential for normal blood clotting. Individuals with hemophilia have deficiencies in these clotting factors, making it difficult to form a stable clot during bleeding episodes. Plasma-derived clotting factor concentrates, processed from donated human plasma, are used to supplement these missing or deficient clotting factors. These concentrates specifically isolate and enhance the necessary clotting factors needed by individuals with hemophilia.

By infusing plasma-derived clotting factor concentrates, individuals with hemophilia can restore the missing or deficient clotting factors in their blood. This helps promote proper blood clotting and prevents or stops bleeding episodes. The specific clotting factors administered depend on the type and severity of hemophilia the individual has. Read Mitchel’s story here.

In summary, plasma-derived therapies (PDT) and plasma donors, such as those at BioLife, play a vital role in greatly improving the quality of life by providing individuals with hemophilia the necessary clotting factors that are deficient in their blood. Utilizing plasma for hemophilia treatments has become a cornerstone in managing this challenging condition, offering hope and improved quality of life to those affected by bleeding disorders.

Thank you for helping us give hope to people with Hemophilia and other rare diseases!

Donating for the first time? Here are 8 Tips for New Plasma Donors From Experienced Plasma Donors and you can find your closest BioLife plasma donation center here.

How often can you donate plasma?

Blog List Title

Text Component Title 1